Teva Pharmaceutical Industries Ltd

MENORA MIVTACHIM HOLDINGS LTD. TEVA

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/12/2026

Shares

39,316,183

Value ($000)

1,227,058

Weight

5.8%

2013 Q4 - 2025 Q4 (27 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/12/2026	1,227,058	5.8%	39,316,183	12/31/2025
2025 Q3	11/13/2025	786,190	4.0%	38,920,294	9/30/2025
2025 Q2	8/14/2025	645,148	3.7%	38,493,294	6/30/2025
2025 Q1	5/13/2025	448,640	2.9%	29,189,316	3/31/2025
2024 Q4	2/13/2025	625,523	3.9%	28,381,242	12/31/2024
2024 Q3	11/14/2024	519,661	3.3%	28,838,039	9/30/2024
2024 Q2	8/13/2024	468,618	3.2%	28,838,039	6/30/2024
2024 Q1	5/13/2024	396,897	3.0%	28,128,744	3/31/2024
2023 Q4	2/14/2024	293,664	2.5%	28,128,744	12/31/2023
2023 Q3	11/14/2023	286,913	2.6%	28,128,744	9/30/2023
2023 Q2	7/31/2023	200,137	1.8%	26,578,560	6/30/2023
2023 Q1	5/15/2023	235,775	2.4%	26,641,218	3/31/2023
2022 Q4	2/14/2023	212,173	3.6%	23,264,560	12/31/2022
2022 Q3	11/14/2022	188,092	3.5%	23,307,560	9/30/2022
2022 Q2	8/8/2022	175,296	3.2%	23,310,610	6/30/2022
2022 Q1	5/12/2022	218,887	3.2%	23,310,610	3/31/2022
2021 Q4	2/10/2022	184,248	2.5%	23,002,282	12/31/2021
2021 Q3	11/15/2021	190,558	2.8%	19,564,520	9/30/2021
2021 Q2	8/9/2021	161,904	2.3%	16,353,960	6/30/2021
2021 Q1	5/11/2021	188,725	3.1%	16,353,960	3/31/2021
2020 Q4	2/11/2021	146,339	2.6%	15,164,710	12/31/2020
2020 Q3	11/3/2020	120,193	2.7%	13,340,000	9/30/2020
2020 Q2	8/5/2020	221,015	5.4%	17,925,000	6/30/2020
2020 Q1	5/5/2020	148,664	4.1%	16,555,000	3/31/2020
2019 Q4	1/30/2020	82,369	2.0%	8,405,000	12/31/2019
2014 Q1	5/13/2014	51,161	4.2%	968,234	3/31/2014
2013 Q4	2/14/2014	49,422	4.3%	1,233,095	12/31/2013